1277602897195384836

Many patients in the U.S. who are in need of a bone marrow transplant (#BMT) don’t receive one. We’re advancing our Phase 3 investigational cell therapy, omidubicel, to potentially enable more patients to receive a bone marrow transplant. Learn more here: https://t.co/hHwIKpk6xc https://t.co/teMN9B6SJU

Send us a message